Literature DB >> 10049744

Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.

D Russell-Harde1, T C Wagner, H D Perez, E Croze.   

Abstract

Human type I interferons (IFN) require two receptor chains, IFNAR1 and IFNAR2c for high affinity (pM) binding and biological activity. Our previous studies have shown that the ligand dependent assembly of the type I IFN receptor chains is not identical for all type I IFNs. IFNbeta appears unique in its ability to assemble a stable complex of receptor chains, as demonstrated by the observation that IFNAR2c co-immunoprecipitates with IFNAR1 when cells are stimulated with IFNbeta but not with IFNalpha. The characteristics of such a receptor complex are not well defined nor is it understood if differential signaling events can be mediated by variations in receptor assembly. To further characterize the factors required for formation of such a stable receptor complex we demonstrate using IFN stimulated Daudi cells that (1) IFNAR2c co-immunoprecipitates with IFNAR1 even when tyrosine phosphorylation of receptor chains is blocked with staurosporine, and (2) IFNbeta1b but not IFNalpha2, is present in the immunoprecipitated receptor complex. These results demonstrate that the unique IFNbeta induced assembly of type I IFN receptor chains is independent of receptor tyrosine phosphorylation and the recruitment of additional proteins to the receptor by such events. Furthermore, the presence of IFNbeta1b in the immunoprecipitated IFN receptor complex suggests that IFNbeta interacts and binds differently to the receptor than IFNalpha2. These results suggest that the specific assembly of type I IFN receptor chains is ligand dependent and may represent an early event which leads to the differential biological responses observed among type I IFNs. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049744     DOI: 10.1006/bbrc.1998.0105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.

Authors:  Christopher D Krause; Gina Digioia; Lara S Izotova; Junxia Xie; Youngsun Kim; Barbara J Schwartz; Olga V Mirochnitchenko; Sidney Pestka
Journal:  Cytokine       Date:  2013-07-03       Impact factor: 3.861

2.  Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.

Authors:  Sabine R Quadt-Akabayov; Jordan H Chill; Rina Levy; Naama Kessler; Jacob Anglister
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

3.  Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.

Authors:  Adelle P McFarland; Ram Savan; Sagie Wagage; Augustina Addison; Karthika Ramakrishnan; Megan Karwan; Tri Duong; Howard A Young
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

Review 4.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

5.  Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.

Authors:  Diego A Jaitin; Laila C Roisman; Eva Jaks; Martynas Gavutis; Jacob Piehler; Jose Van der Heyden; Gilles Uze; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.

Authors:  Zrinka Marijanovic; Josiane Ragimbeau; José van der Heyden; Gilles Uzé; Sandra Pellegrini
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

7.  MxA gene expression analysis as an interferon-beta bioactivity measurement in patients with multiple sclerosis and the identification of antibody-mediated decreased bioactivity.

Authors:  Andrew Pachner; Kavitha Narayan; Nicholson Price; Marie Hurd; Donna Dail
Journal:  Mol Diagn       Date:  2003

8.  Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling.

Authors:  Tiffany Tran; Pedro Paz; Sharlene Velichko; Jill Cifrese; Praveen Belur; Ken D Yamaguchi; Karin Ku; Parham Mirshahpanah; Anthony T Reder; Ed Croze
Journal:  Int J Cell Biol       Date:  2011-01-17

9.  Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.

Authors:  Stephan Wilmes; Oliver Beutel; Zhi Li; Véronique Francois-Newton; Christian P Richter; Dennis Janning; Cindy Kroll; Patrizia Hanhart; Katharina Hötte; Changjiang You; Gilles Uzé; Sandra Pellegrini; Jacob Piehler
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

10.  Combinatorial cytokine code generates anti-viral state in dendritic cells.

Authors:  Boris M Hartmann; Nada Marjanovic; German Nudelman; Thomas M Moran; Stuart C Sealfon
Journal:  Front Immunol       Date:  2014-02-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.